Posted On: 12/07/2014 9:21:45 AM
Post# of 63824
$LJPC 10-bagger consolidating at $11.43
Website
40% BUY
Shares Outstanding: 15.22M
Float: 8.02M
% Held by Insiders: 35.09%
% Held by Institutions: 17.20%
Shares Short (as of Nov 14, 2014): 579.02K
Short Ratio (as of Nov 14, 2014): 3.20
Short % of Float (as of Nov 14, 2014): 7.00%
Shares Short (prior month): 527.04K
10-Q 11/12/14
Summary
Recent Trades
Headlines
Friday, November 21, 2014
LA JOLLA PHARMACEUTICAL CO FinancialsEDGAR Online Financials
Tuesday, November 18, 2014
LA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, FinancialEDGAR Online
Friday, November 14, 2014
10-Q for La Jolla Pharmaceutical Co.Company Spotlight
Wednesday, November 12, 2014
La Jolla Pharmaceutical posts 3Q lossAP
Results from Phase 2 Study of GCS-100 in Chronic Kidney Disease Being Presented at American Society of Nephrology Kidney WeekBusiness Wire
LA JOLLA PHARMACEUTICAL CO Files SEC form 10-Q, Quarterly ReportEDGAR Online
La Jolla Pharmaceutical Company Announces Third Quarter and Year-to-Date 2014 Financial Results and Corporate HighlightsBusiness Wire
Monday, November 10, 2014
La Jolla Pharmaceutical (LJPC) in Focus: Stock Surges 10.2%Zacks
Monday, October 27, 2014
La Jolla Pharmaceutical Co. (LJPC) Jumps: Stock Rises 10.3%Zacks
Thursday, October 23, 2014
La Jolla Pharmaceutical Company Announces Data Presentation at the American Society of Nephrology Kidney WeekBusiness Wire
Wednesday, October 22, 2014
La Jolla (LJPC) Shares March Higher, Can It Continue?Zacks
Tuesday, October 14, 2014
LA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online
Tuesday, September 16, 2014
La Jolla (LJPC) is Oversold: Can It Recover?Zacks
Monday, September 8, 2014
La Jolla Pharmaceutical Company to Provide Corporate Overview at the Rodman & Renshaw 16th Annual Global Investment ConferenceBusiness Wire
Sunday, August 31, 2014
Using Mean Reversion and Momentum for Possible AdvantageYahoo Finance Blogs
Friday, August 29, 2014
LA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to aEDGAR Online
Two Portfolios. Pick One.Yahoo Finance Blogs
Monday, August 25, 2014
La Jolla Pharmaceutical Company Announces First Patient Enrolled in Clinical Trial of LJPC-501 in Hepatorenal SyndromeBusiness Wire
Thursday, August 14, 2014
LA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements anEDGAR Online
La Jolla Pharmaceutical Company Announces Second Quarter and Year-to-Date 2014 Financial ResultsBusiness Wire
Website
40% BUY
Shares Outstanding: 15.22M
Float: 8.02M
% Held by Insiders: 35.09%
% Held by Institutions: 17.20%
Shares Short (as of Nov 14, 2014): 579.02K
Short Ratio (as of Nov 14, 2014): 3.20
Short % of Float (as of Nov 14, 2014): 7.00%
Shares Short (prior month): 527.04K
10-Q 11/12/14
Summary
Recent Trades
Headlines
Friday, November 21, 2014
LA JOLLA PHARMACEUTICAL CO FinancialsEDGAR Online Financials
Tuesday, November 18, 2014
LA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, FinancialEDGAR Online
Friday, November 14, 2014
10-Q for La Jolla Pharmaceutical Co.Company Spotlight
Wednesday, November 12, 2014
La Jolla Pharmaceutical posts 3Q lossAP
Results from Phase 2 Study of GCS-100 in Chronic Kidney Disease Being Presented at American Society of Nephrology Kidney WeekBusiness Wire
LA JOLLA PHARMACEUTICAL CO Files SEC form 10-Q, Quarterly ReportEDGAR Online
La Jolla Pharmaceutical Company Announces Third Quarter and Year-to-Date 2014 Financial Results and Corporate HighlightsBusiness Wire
Monday, November 10, 2014
La Jolla Pharmaceutical (LJPC) in Focus: Stock Surges 10.2%Zacks
Monday, October 27, 2014
La Jolla Pharmaceutical Co. (LJPC) Jumps: Stock Rises 10.3%Zacks
Thursday, October 23, 2014
La Jolla Pharmaceutical Company Announces Data Presentation at the American Society of Nephrology Kidney WeekBusiness Wire
Wednesday, October 22, 2014
La Jolla (LJPC) Shares March Higher, Can It Continue?Zacks
Tuesday, October 14, 2014
LA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online
Tuesday, September 16, 2014
La Jolla (LJPC) is Oversold: Can It Recover?Zacks
Monday, September 8, 2014
La Jolla Pharmaceutical Company to Provide Corporate Overview at the Rodman & Renshaw 16th Annual Global Investment ConferenceBusiness Wire
Sunday, August 31, 2014
Using Mean Reversion and Momentum for Possible AdvantageYahoo Finance Blogs
Friday, August 29, 2014
LA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to aEDGAR Online
Two Portfolios. Pick One.Yahoo Finance Blogs
Monday, August 25, 2014
La Jolla Pharmaceutical Company Announces First Patient Enrolled in Clinical Trial of LJPC-501 in Hepatorenal SyndromeBusiness Wire
Thursday, August 14, 2014
LA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements anEDGAR Online
La Jolla Pharmaceutical Company Announces Second Quarter and Year-to-Date 2014 Financial ResultsBusiness Wire
(0)
(0)
